Search

everythinglearnresearchcommunity

for

Search:↓

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Most children with childhood-onset lupus in Baghdad responded well to treatment, but some developed chronic kidney disease or died.

Tofacitinib is an effective and safe treatment for alopecia areata.

PRP is an effective and safe treatment for female hair loss.

Using minoxidil daily with monthly minoxidil mesotherapy is more effective for hair loss than monthly PRP microneedling treatments.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Phototherapy is effective and well-tolerated for treating childhood psoriasis and pityriasis lichenoides chronica.

Early treatment of acne is crucial to prevent scarring and psychological effects.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The comment questions the study's methods for diagnosing hair loss, the type of injections used, the reliability of hair count as a measure, the lack of detail about the procedure, and disagrees with the conclusion about the effect of needling.

Platelet rich plasma is an effective treatment for alopecia areata.

Topical tofacitinib is effective and safe for treating alopecia areata.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

0.05% Betamethasone Dipropionate is the most effective topical treatment for alopecia areata.